14-day Premium Trial Subscription Try For FreeTry Free
$25.38
+0.0200 (+0.0789%)
At Close: May 02, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $14.00 $25.47 Thursday, 2nd May 2024 DCPH stock ended at $25.38. This is 0.0789% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 0.493% from a day low at $25.35 to a day high of $25.47.
90 days $13.86 $25.47
52 weeks $9.90 $25.47

Historical Deciphera Pharmaceuticals Inc prices

Date Open High Low Close Volume
Dec 07, 2023 $13.54 $15.54 $13.49 $15.07 1 969 919
Dec 06, 2023 $13.36 $13.76 $13.17 $13.48 359 164
Dec 05, 2023 $13.32 $13.44 $13.06 $13.33 535 331
Dec 04, 2023 $12.80 $13.44 $12.80 $13.35 619 378
Dec 01, 2023 $12.54 $12.94 $12.40 $12.94 527 214
Nov 30, 2023 $12.51 $12.90 $12.51 $12.61 620 099
Nov 29, 2023 $12.28 $12.81 $12.28 $12.40 460 489
Nov 28, 2023 $12.12 $12.23 $11.97 $12.19 327 864
Nov 27, 2023 $12.27 $12.27 $11.93 $12.11 327 128
Nov 24, 2023 $12.03 $12.33 $12.03 $12.24 145 633
Nov 22, 2023 $12.24 $12.34 $12.06 $12.13 205 826
Nov 21, 2023 $12.20 $12.29 $12.01 $12.09 377 516
Nov 20, 2023 $11.98 $12.66 $11.81 $12.34 317 279
Nov 17, 2023 $12.38 $12.39 $12.03 $12.16 663 570
Nov 16, 2023 $12.32 $12.47 $11.81 $12.25 628 423
Nov 15, 2023 $12.30 $12.76 $12.30 $12.34 552 408
Nov 14, 2023 $12.15 $12.50 $12.07 $12.34 724 385
Nov 13, 2023 $11.43 $11.71 $11.16 $11.63 1 176 628
Nov 10, 2023 $11.39 $11.61 $11.14 $11.51 420 999
Nov 09, 2023 $11.86 $11.86 $11.13 $11.31 413 491
Nov 08, 2023 $11.89 $12.03 $11.55 $11.73 365 116
Nov 07, 2023 $12.12 $12.33 $11.84 $11.90 487 254
Nov 06, 2023 $12.22 $12.50 $11.89 $12.06 435 766
Nov 03, 2023 $11.91 $12.72 $11.91 $12.15 1 563 530
Nov 02, 2023 $11.82 $12.09 $11.55 $11.74 888 797
Click to get the best stock tips daily for free!

About Deciphera Pharmaceuticals Inc

Deciphera Pharmaceuticals Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. Th... DCPH Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT